Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 2/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225137 | 0.89 | GRM5 (0.35) | GRM5HCRTR1PIK3CA | |
| SCHEMBL7231547 | 0.89 | CHRNB2 (0.36) | GRM5CHRNB2CHRNA4HCRTR1 | |
| SCHEMBL7226063 | 0.88 | SLC6A3 (0.38) | CHRNB2CHRNA4 | |
| SCHEMBL7223713 | 0.88 | CHRNA7 (0.34) | CHRNB2CHRNA4 | |
| SCHEMBL7224292 | 0.86 | MAOA (0.38) | GRM5HCRTR1PIK3CA | |
| SCHEMBL7224085 | 0.85 | GRM5 (0.34) | GRM5SMYD3HCRTR1 | |
| SCHEMBL7225406 | 0.83 | SLC6A2 (0.33) | — | |
| SCHEMBL7233574 | 0.83 | DGAT1 (0.33) | CHRNB2CHRNA4SMYD3HCRTR1 | |
| SCHEMBL7224375 | 0.82 | SLC6A2 (0.38) | SMYD3 | |
| SCHEMBL7232894 | 0.82 | SLC6A4 (0.38) | CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | claimed |
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | disclosed |